The Gamble Behind a Takeover of Kenvue, Maker of Tylenol

Written by

in

The New York Times – Business:

Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.

This post first appeared in The New York Times – Business. Read the original article.